Skip to content

Continuous Glucose Monitoring and Hospitalization Outcomes in Adults with Insulin-Treated Type 2 Diabetes and Complex Care Needs: A Population-Based Study.

Sep 2026 · Diabetes Technology & Therapeutics · pp. 15209156261492377 · 0 citations · 29 references
Medicine

TL;DR

In this population-based cohort of adults with insulin-treated T2D and CCN, CGM initiation was associated with fewer hospitalizations, shorter hospital stays, and lower hospitalization costs, supporting the integration of diabetes technology into chronic care strategies for highly vulnerable populations.

Abstract

Aim

Continuous glucose monitoring (CGM) improves glycemic outcomes in insulin-treated type 2 diabetes (T2D), but evidence in individuals with complex care needs (CCN) is limited. We evaluated the association between CGM initiation and hospitalization outcomes in a population-based cohort of adults with insulin-treated T2D and CCN.

Methods

We conducted a population-based quasi-experimental study including all eligible adults with insulin-treated T2D and CCN who initiated CGM through the Andalusian Public Health System. Rates of acute diabetes-related complications and cardiovascular admissions were compared before and after CGM initiation using Poisson regression models adjusted for person-time. Interrupted time-series analyses, length of stay (LOS), and hospitalization costs were also evaluated.

Results

Of 17,561 adults initiating CGM, 5281 met criteria for CCN and were included (mean age 79 years; 55.1% aged ≥ 80 years). Acute diabetes-related hospitalization rates decreased from 144.27 to 41.04 per 10,000 person-years (rate ratio [RR] 0.28, 95% CI 0.19-0.42), and cardiovascular admission rates decreased from 387.25 to 251.96 per 10,000 person-years (RR 0.65, 95% CI 0.54-0.78). Interrupted time-series analyses showed post-intervention hospitalization rates consistently below counterfactual estimates. Mean LOS decreased by 3.68 days (95% CI -5.26 to -2.10; P < 0.001), and hospitalization costs decreased by USD657.39 per patient-year.

Conclusion

In this population-based cohort of adults with insulin-treated T2D and CCN, CGM initiation was associated with fewer hospitalizations, shorter hospital stays, and lower hospitalization costs, supporting the integration of diabetes technology into chronic care strategies for highly vulnerable populations.

View source

Similar papers

Open access Oct 2026

Evaluation of continuous glucose monitoring outcomes and health care resource utilization in patients with non-insulin-treated type 2 diabetes.

BACKGROUND Although continuous glucose monitoring (CGM) is well established for insulin-treated diabetes, its utility in non-insulin-treated type 2 diabetes (T2D) remains less studied. OBJECTIVE To evaluate the short-term clinical and economic outcomes following personal use of CGM in patients with T2D. METHODS Thi...

S. Gadd, Connor W. Willis, Ishfaq Rashid et al. · 0 citations
Review Open access Oct 2026

Effectiveness of Continuous Glucose Monitoring in Non-Intensively Managed Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

BACKGROUND The effectiveness of continuous glucose monitoring (CGM) in adults with type 2 diabetes (T2D) not receiving intensive insulin therapy remains incompletely established, particularly regarding glycemic metrics beyond glycated hemoglobin (HbA1c). METHODS We conducted a systematic review and meta-analysis of r...

A. A. Al Hayek, Wael M. Alzahrani, Haifa F. Alotaibi et al. · 0 citations
Open access Oct 2026

Hospitalization in adults aged 75 years and older with type 2 diabetes: the role of kidney impairment and glycemic control

Older adults aged ≥ 75 years with type 2 diabetes (T2D) experience high healthcare utilization, yet evidence on treatment patterns and outcomes in this age group is limited. To assess associations between glycemic control, kidney function, and hospitalization among individuals aged ≥ 75 years with T2D. Individuals aged...

Bertin Magamba, J. M. Jonasson, Louise Pettersson et al. · 0 citations
Open access Sep 2026

Continuous Glucose Monitoring Reduces Severe Diabetes Distress Independently of Glycemic Improvement in Adults With Type 1 Diabetes: A Prospective Study in a Public Healthcare Setting.

OBJECTIVES While technology improves glycemic control, its psychological impact in resource-limited settings is less explored. This study evaluated the impact of continuous glucose monitoring (CGM) on diabetes distress and glycemic outcomes in adults with type 1 diabetes (T1D) within a public healthcare system. METHO...

Nathalia Costa Monteiro, Laís Prado Smith Lima, J. P. A. Freitas et al. · 0 citations
Open access Sep 2026

Timing of continuous glucose monitoring initiation and long-term glycemic trajectories in pediatric type 1 diabetes.

Purpose The long-term impact of continuous glucose monitoring (CGM) initiation on glycemic trajectories in children and adolescents with type 1 diabetes (T1D) remains unclear. We assessed 5-year glycated hemoglobin (HbA1c) trajectories according to CGM initiation timing in Korean children and adolescents with T1D. Me...

Jun-Ha Dong, H. Kim, Jaehyun Kim · 0 citations
Open access Aug 2026

Effects of statins on glycemic control and cardiovascular events in patients with new-onset type 2 diabetes: a retrospective cohort study

In patients with new-onset T2D, early statin initiation is associated with worse short-term glycemic improvement and a greater need for escalating glucose-lowering therapy; however, it is also associated with a substantial reduction in the long-term MACE risk.

Ying Ran, Li-Li Jiang, Jing Ran et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.